Nathan D Seligson

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

The Annals of pharmacotherapy

Pharmacy (Basel, Switzerland)

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Emilie J Bergsma, Mariam Elgawly, David Mancuso, Roger Orr, Theresa Vuskovich, Nathan D Seligson
Atezolizumab as the First Systemic Therapy Approved for Alveolar Soft Part Sarcoma. The Annals of pharmacotherapy (2023)
Nathan D Seligson, Jill M Kolesar, Benish Alam, Laura Baker, Jatinder Kaur Lamba, Brooke L Fridley, Ameen A Salahudeen, Daniel Louis Hertz, J Kevin Hicks
Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer. Pharmacogenomics (2023)
Kelsey J Cook, Victoria Grusauskas, Lucy Gloe, Benjamin Q Duong, Renee C Gresh, E Anders Kolb, Manisha Bansal, Allison S Bechtel, Ramamoorthy Nagasubramanian, Susan M Kirwin, Kathryn V Blake, Nathan D Seligson
Comparison of variants in TPMT and NUDT15 between sequencing and genotyping methods in a multistate pediatric institution. Clinical and translational science (2023)
Kevan King, Hannah E Davis, Robin Moorman-Li, Kelsey J Cook, Nathan D Seligson
Development of a Campus-Wide Community Service Initiative during a Pandemic. Pharmacy (Basel, Switzerland) 10 (3) (2022)
Nam H K Nguyen, Roya Rafiee, Abderrahmane Tagmount, Amin Sobh, Alex Loguinov, Angelica K de Jesus Sosa, Abdelrahman H Elsayed, Mohammed O Gbadamosi, Nathan D Seligson, Christopher R Cogle, Jeffrey E Rubnitz, Raul C Ribeiro, James R Downing, Xueyuan Cao, Stanley B Pounds, Christopher D Vulpe, Jatinder Kaur Lamba
Genome-wide CRISPR/Cas9 Screen Identifies Etoposide Response Modulators Associated with Outcomes in Pediatric AML. Blood advances (2022)
Ryan S Nelson, Nathan D Seligson, Sal Bottiglieri, Estrella Carballido, Alex Del Cueto, Iman Imanirad, Richard Levine, Alexander S Parker, Sandra M Swain, Emma M Tillman, J Kevin Hicks
UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 13 (7) (2021)
John M Seligson, Alexandra M Patron, Michael J Berger, R Donald Harvey, Nathan D Seligson
Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer. The Annals of pharmacotherapy 55 (7) (2020)